Loomis Sayles & CO L P Abbott Laboratories Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

A detailed history of Loomis Sayles & CO L P transactions in Abbott Laboratories stock. As of the latest transaction made, Loomis Sayles & CO L P holds 99,116 shares of ABT stock, worth $11.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

99,116

Previous 67,095 47.72%

Holding current value

$11.1 Million

Previous $6.97 Million 62.09%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $3.2 Million - $3.78 Million	32,021 Added 47.72%	99,116 $11.3 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $1.37 Million - $1.53 Million	13,608 Added 25.44%	67,095 $6.97 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $506,091 - $558,956	-4,621 Reduced 7.95%	53,487 $6.08 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $2.37 Million - $2.9 Million	26,261 Added 82.46%	58,108 $6.4 Million
Q3 2023 Nov 09, 2023	SELL	$95.53 - $114.62 $148,740 - $178,463	-1,557 Reduced 4.66%	31,847 $3.08 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $555,297 - $618,717	-5,510 Reduced 14.16%	33,404 $3.64 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $100,831 - $118,684	1,041 Added 2.75%	38,914 $3.94 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $575,303 - $674,919	6,052 Added 19.02%	37,873 $4.16 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $9.77 Million - $11.3 Million	-100,991 Reduced 76.04%	31,821 $3.08 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $8.31 Million - $10 Million	-81,391 Reduced 38.0%	132,812 $14.4 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $9.23 Million - $11.3 Million	-80,958 Reduced 27.43%	214,203 $25.4 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $10.3 Million - $12.6 Million	-89,390 Reduced 23.25%	295,161 $41.5 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2.63 Million - $2.91 Million	22,536 Added 6.23%	384,551 $45.4 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $2.28 Million - $2.68 Million	-21,526 Reduced 5.61%	362,015 $42 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $30.3 Million - $35.7 Million	278,065 Added 263.63%	383,541 $46 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $10.8 Million - $11.8 Million	103,155 Added 4444.42%	105,476 $11.5 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $154,596 - $187,746	1,687 Added 266.09%	2,321 $253,000
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $2,603 - $3,332	-34 Reduced 5.09%	634 $58,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $130,037 - $190,150	-2,070 Reduced 75.6%	668 $53,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $4,161 - $4,632	-53 Reduced 1.9%	2,738 $238,000
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $1.77 Million - $1.92 Million	-21,595 Reduced 88.55%	2,791 $234,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $1.61 Million - $1.87 Million	22,049 Added 943.47%	24,386 $2.05 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $2.3 Million - $2.78 Million	-34,781 Reduced 93.7%	2,337 $187,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $3.68 Million - $4.16 Million	-56,071 Reduced 60.17%	37,118 $2.69 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $13.8 Million - $16.6 Million	-226,821 Reduced 70.88%	93,189 $6.84 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $6.54 Million - $7.22 Million	-113,603 Reduced 26.2%	320,010 $19.5 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $5.93 Million - $6.7 Million	-105,313 Reduced 19.54%	433,613 $26 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $21.8 Million - $23.4 Million	-406,307 Reduced 42.98%	538,926 $30.8 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $5.38 Million - $6 Million	-111,855 Reduced 10.58%	945,233 $50.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,057,088	1,057,088 $51.4 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Abbott Laboratories Transaction History